ANZUP TheraP Study @ ASCO GU 2021

Lutetium-177 PSMA-617 versus cabazitaxel in metastatic castration resistant prostate cancer progressing after docetaxel

Presented by Professor Michael Hofman, Peter MacCallum Cancer Centre Melbourne
at the ASCO Genitourinary Cancers Symposium 2021

Published in the Lancet: download from: https://www.sciencedirect.com/science...